[ 1 ] Schuurman MS, van Den Einden LC, Massuger LF, et al. Trends in incidence and survival of Dutch women with vulvar squamous cell carcinoma[J]. Eur J Cancer, 2013, 49(18): 3872-3880.
[2]
[ 2 ] H？ckel M, Schmidt K, Bornmann K, et al. Vulvar field resection: novel approach to the surgical treatment of vulvar cancer based on ontogenetic anatomy[J]. Gynecol Oncol, 2010, 119(1): 106-113.
[3]
[ 3 ] Richter AM, Pfeifer GP, Dammann RH. The RASSF proteins in cancer; from epigenetic silencing to functional characterization[J]. Biochim Biophys Acta, 2009, 1796(2): 114-128.
[4]
[ 4 ] Mitra S, Mazumder Indra D, Basu PS, et al. Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance[J]. Mol Carcinog, 2012, 51(9): 723-733.
[5]
[ 5 ] Maliukova AV, Loginov VI, Khodyrev DS, et al. Methylation of the putative tumor suppressor gene, RASSF1A, in primary cervical tumors[J]. Mol Biol (Mosk), 2004, 38(6): 1005-1013.
[ 7 ] Fiolka R, Zubor P, Janusicova V, et al. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer[J]. Oncol Rep, 2013, 30(6): 2878-2886.
[8]
[ 8 ] Shi H, Li Y, Wang X, et al. Association between RASSF1A promoter methylation and ovarian cancer: a meta-analysis[J]. PLoS One, 2013, 8(10): e76787.
[9]
[ 9 ] Zhang Q, Hu G, Yang Q, et al. A multiplex methylation-specific PCR assay for the detection of early-stage ovarian cancer using cell-free serum DNA[J]. Gynecol Oncol, 2013, 130(1): 132-139.
[10]
Dammann R, Li C, Yoon JH, et al. Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3[J]. Nat Genet, 2000, 25(3): 315-319.
[11]
Knudson AG. Hereditary cancer: two hits revisited[J]. J Cancer Res Clin Oncol, 1996, 122(3): 135-140.
[12]
Agathanggelou A, Honorio S, Macartney DP, et al. Methylation associated inactivation of RASSF1A from region 3p21.3 in lung, breast and ovarian tumours[J]. Oncogene, 2001, 20(12): 1509-1518.
Vos MD, Ellis CA, Bell A, et al. Ras uses the novel tumor suppressor RASSF1A as an effector to mediate apoptosis[J]. J Biol Chem, 2000, 275(46): 35669-35672.
[16]
Kim JH, Choi YD, Lee JS, et al. Quantitative assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens[J]. Virchows Arch, 2010, 457(1): 35-42.
[17]
Christman JK. 5-Azacytidine and 5-aza-2’-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy[J]. Oncogene, 2002, 21(35): 5483-5495.
[18]
Steiner M, Clark B, Tang JZ, et al. 14-3-3σ mediates G2-M arrest produced by 5-aza-2’-deoxycytidine and possesses a tumor suppressor role in endometrial carcinoma cells[J]. Gynecol Oncol, 2012, 127(1): 231-240.
